Al Hammadi Holding Company (TADAWUL:4007)

Saudi Arabia · Delayed Price · Currency is SAR

27.16

-0.14 (-0.51%)

Jul 2, 2026, 3:14 PM AST

-28.86% (1Y)

Market Cap	4.35B -26.4%
Revenue (ttm)	1.25B +6.2%
Net Income	224.17M -35.7%
EPS	1.40 -35.7%
Shares Out	160.00M
PE Ratio	19.39
Forward PE	16.26
Dividend	0.80 (2.95%)
Ex-Dividend Date	Jun 2, 2026

Volume	107,162
Open	27.42
Previous Close	27.30
Day's Range	27.10 - 27.46
52-Week Range	23.42 - 38.40
Beta	0.01
Analysts	Buy
Price Target	35.80 (+31.81%)
Earnings Date	Aug 6, 2026

About TADAWUL:4007

Al Hammadi Holding Company, a healthcare group, provides healthcare services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. The company offers inpatient and outpatient hospital services, including accommodation, medical professional services, equipment, radiology, laboratory, and bundled healthcare offerings; and provides medical services. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in ... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1985

Country Saudi Arabia

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4007

Full Company Profile

Financial Performance

In 2025, TADAWUL:4007's revenue was 1.23 billion, an increase of 6.99% compared to the previous year's 1.15 billion. Earnings were 241.86 million, a decrease of -28.61%.

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for 4007 stock is "Buy." The 12-month stock price target is SAR 35.80, which is an increase of 31.81% from the latest price.

Price Target

SAR 35.80

(31.81% upside)

Analyst Consensus: Buy

Stock Forecasts